Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Fresenius SE & Co KGAA O.N. (FREG)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
27.21 +0.15    +0.55%
26/04 - Closed. Currency in EUR ( Disclaimer )
  • Volume: 35,319
  • Bid/Ask: 27.21 / 27.45
  • Day's Range: 26.93 - 27.44
Type:  Equity
Market:  Germany
ISIN:  DE0005785604 
S/N:  578560
Fresenius SE 27.21 +0.15 +0.55%

FREG Income Statement & Profits

 
Assess the Fresenius SE income statement, view the company's financial performance across their assets and liabilities. Select to view either quarterly or annual data.
AnnualQuarterly
InvestingPro Advanced Income Statement
Period Ending: 2022
31/03
2021
31/12
2021
30/09
2021
30/06
Total Revenue 9720 9966 9324 9246
Revenue 9720 9966 9324 9246
Other Revenue, Total - - - -
Cost of Revenue, Total 7162 7254 6801 6628
Gross Profit 2558 2712 2523 2618
Total Operating Expenses 8818 8843 8316 8225
Selling/General/Admin. Expenses, Total 1488 1487 1300 1400
Research & Development 174 197 198 186
Depreciation / Amortization 5 6 6 5
Interest Expense (Income) - Net Operating -11 - - -
Unusual Expense (Income) - 4 11 6
Other Operating Expenses, Total - -105 - -
Operating Income 902 1123 1008 1021
Interest Income (Expense), Net Non-Operating -118 -122 -126 -121
Gain (Loss) on Sale of Assets - - - -
Other, Net - - - -
Net Income Before Taxes 784 1001 882 900
Provision for Income Taxes 185 242 201 192
Net Income After Taxes 599 759 681 708
Minority Interest -186 -260 -268 -237
Equity In Affiliates - - - -
U.S GAAP Adjustment - - - -
Net Income Before Extraordinary Items 413 499 413 471
Total Extraordinary Items - - - -
Net Income 413 499 413 471
Total Adjustments to Net Income - - - -
Income Available to Common Excluding Extraordinary Items 413 499 413 471
Dilution Adjustment - - - -
Diluted Net Income 413 499 413 471
Diluted Weighted Average Shares 558.5 558.49 558.11 560.71
Diluted EPS Excluding Extraordinary Items 0.74 0.89 0.74 0.84
DPS - Common Stock Primary Issue - 0.92 - -
Diluted Normalized EPS 0.54 0.68 0.77 0.6
* In Millions of (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

FREG Price Commentary

Write your thoughts about Fresenius AG
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Federica Catalani
Federica Catalani Jan 10, 2022 11:47
Saved. See Saved Items.
This comment has already been saved in your Saved Items
on Market Miracle Advisor came out a purchase signal for FREG that has a target gain in percentage of 25% and that could be reached within 113 days From the chart they publish it seems that there is a considerable increase in interest from professional investors while the institutions are still short but seem to reduce the short slightly. I would say very interesting in the medium / long term
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email